Health Catalyst, Inc. (NASDAQ:HCAT) Q2 2025 Earnings Call Transcript
Operator: Welcome to the Health Catalyst Second Quarter 2025 Earnings Conference Call.
Health Catalyst Inc. (HCAT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Whetstone Capital Advisors David Atterbury | 3,731,350 | $14,067,190 | +119% | 3.97% |
| 2. | Impax Asset Management Ian Simm | 2,750,000 | $10,367,500 | 0.06% | |
| 3. | Portolan Capital Management George Mccabe | 1,980,409 | $7,466,142 | +51% | 0.47% |
| 4. | Alyeska Investment Group Anand Parekh | 346,089 | $1,304,756 | -1% | 0% |
| 5. | Moore Global Investments Louis Bacon | 172,834 | $651,584 | -21% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.81 | 26,200 | $204,525.06 | 1,172,623 | 2024-02-27 | Filing | |
| $10.19 | 49,050 | $499,593.87 | 919,415 | 2023-05-12 | Filing | |
| $10.14 | 197,078 | $1,998,213.26 | 900,140 | 2022-11-11 | Filing | |
| $10.99 | 90,750 | $996,970.43 | 703,062 | 2022-09-08 | Filing | |
| $11.63 | 6,600 | $76,750.74 | 35,405 | 2022-08-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.35 | 6,175 | $20,704.78 | 141,812 | 2025-09-05 | Filing | |
| $3.94 | 6,057 | $23,890.63 | 151,125 | 2025-06-05 | Filing | |
| $4.10 | 5,209 | $21,331.38 | 205,832 | 2025-05-05 | Filing | |
| $4.15 | 5,209 | $21,604.33 | 211,041 | 2025-04-03 | Filing | |
| $4.55 | 13,827 | $62,860.31 | 160,437 | 2025-03-06 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,513,032 | $4,312,141 | 1.37% | |
| 2. | 310,282 | $884,304 | 0.39% | |
| 3. | 76,745 | $218,723 | 0.02% | |
| 4. | 38,529 | $109,808 | 0% | |
| 5. | 26,050 | $74,242 | 0% |
News See All
Wells Fargo Raises PT on Health Catalyst, Inc. (HCAT); Maintains ‘Buy’ Rating
Health Catalyst, Inc.
11 Most Undervalued Cloud Stocks Under $10 According to Hedge Funds
The cloud market is undergoing rapid growth due to rising demand from industries adopting artificial intelligence (AI) technologies.
Health Catalyst, Inc. (NASDAQ:HCAT) Q1 2025 Earnings Call Transcript
Operator: Welcome to the Health Catalyst First Quarter 2025 Earnings Conference Call.
Health Catalyst, Inc. (NASDAQ:HCAT) Q4 2024 Earnings Call Transcript
Operator: Welcome to the Health Catalyst’s Fourth Quarter and Full Year 2024 Earnings Conference Call.
Health Catalyst, Inc. (NASDAQ:HCAT) Q3 2024 Earnings Call Transcript
Operator: Welcome to the Health Catalyst Third Quarter 2024 Earnings Conference Call.
Health Catalyst, Inc. (NASDAQ:HCAT) Q2 2024 Earnings Call Transcript
Operator: Welcome to the Health Catalyst Second Quarter 2024 Earnings Conference Call.
Health Catalyst, Inc. (NASDAQ:HCAT) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, everyone, and welcome to the Health Catalyst First Quarter 2024 Earnings Conference Call. [Operator Instructions].
Health Catalyst, Inc. (NASDAQ:HCAT) Q4 2023 Earnings Call Transcript
Health Catalyst, Inc. beats earnings expectations. Reported EPS is $0.02, expectations were $-0.01. Health Catalyst, Inc.
20 Most Valuable Digital Health Companies In The US
In this article, we will be taking a look at the 20 most valuable digital health companies in the US.